MedTrace Logo

Embr Thermal Device for Hot Flash Management in Prostate Cancer

NCT04892914 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2022-04-05

No results posted yet for this study

Summary

This study is being conducted to evaluate if the Embr thermal device is useful for men who experience bothersome hot flashes as a result of prostate cancer treatment.

Conditions

Interventions

DEVICE

Embr thermal device

Participants use the Embr thermal device for 4 weeks

Sponsors & Collaborators

  • Embr Labs, Inc.

    lead INDUSTRY

Principal Investigators

  • Alicia Morgans, MD, MPH · Northwestern University Feinberg School of Medicine

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-28
Primary Completion
2021-12-05
Completion
2021-12-05

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04892914 on ClinicalTrials.gov